These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29496401)

  • 1. Solvent-Detergent Plasma for the Treatment of Thrombotic Microangiopathies: A Canadian Tertiary Care Centre Experience.
    Lee LJ; Roland KJ; Sreenivasan GM; Zypchen LN; Ambler KLS; Yenson PR
    Transfus Apher Sci; 2018 Apr; 57(2):233-235. PubMed ID: 29496401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of solvent/detergent-treated plasma safety and efficacy in orthotopic liver transplant and thrombotic thrombocytopenic purpura patients: A single center experience.
    McRae HL; Milito C; Klapheke CA; Refaai MA
    Transfusion; 2022 Feb; 62(2):429-438. PubMed ID: 34961945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of plasma exchange using a double viral inactivated and prion reduced solvent/detergent fresh frozen plasma for the treatment of thrombotic microangiopathy: The first French experience in a single center.
    Poullin P; Delmotte N; Sanderson F; Roche M; Gensollen S
    Transfus Apher Sci; 2020 Feb; 59(1):102587. PubMed ID: 31331708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-center prospective study on the safety of plasma exchange procedures using a double-viral-inactivated and prion-reduced solvent/detergent fresh-frozen plasma as the replacement fluid in the treatment of thrombotic microangiopathy.
    Vendramin C; McGuckin S; Alwan F; Westwood JP; Thomas M; Scully M
    Transfusion; 2017 Jan; 57(1):131-136. PubMed ID: 27774620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic microangiopathies.
    Rosove MH
    Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic microangiopathies: Similar presentations, different therapies.
    Appel GB
    Cleve Clin J Med; 2017 Feb; 84(2):114-130. PubMed ID: 28198690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical picture of thrombotic microangiopathy in patients older than 60 years of age.
    Schmidt J; Zafrani L; Lemiale V; Stepanian A; Joly B; Azoulay E; Mariotte E
    Br J Haematol; 2021 Jan; 192(1):e25-e28. PubMed ID: 33216950
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and Safety Profile of Solvent/Detergent Plasma in the Treatment of Acute Thrombotic Thrombocytopenic Purpura: A Single-Center Experience.
    Edel E; Al-Ali HK; Seeger S; Kauschat D; Matthes G
    Transfus Med Hemother; 2010 Feb; 37(1):13-19. PubMed ID: 20737012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombotic microangiopathy: when time is the key factor!].
    Hemett OM; Martins F; Descombes E; Betticher D; Hayoz D
    Rev Med Suisse; 2014 Apr; 10(425):794, 796-803. PubMed ID: 24791425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndromes of Thrombotic Microangiopathy.
    Shatzel JJ; Taylor JA
    Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The revolution of monoclonal antibodies in the treatment of thrombotic microangiopathy].
    Sauvètre G; Grange S; Froissart A; Veyradier A; Coppo P; Benhamou Y
    Rev Med Interne; 2015 May; 36(5):328-38. PubMed ID: 25547956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group].
    Contreras E; de la Rubia J; Del Río-Garma J; Díaz-Ricart M; García-Gala JM; Lozano M;
    Med Clin (Barc); 2015 Apr; 144(7):331.e1-331.e13. PubMed ID: 25433791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of severe adult thrombotic microangiopathies in the intensive care unit.
    Pene F; Vigneau C; Auburtin M; Moreau D; Zahar JR; Coste J; Heshmati F; Mira JP
    Intensive Care Med; 2005 Jan; 31(1):71-8. PubMed ID: 15580333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombotic microangiopathies].
    Starck M; Wendtner CM
    Dtsch Med Wochenschr; 2014 Oct; 139(40):1993-6. PubMed ID: 25254393
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis and management of complement mediated thrombotic microangiopathies.
    Cataland SR; Wu HM
    Blood Rev; 2014 Mar; 28(2):67-74. PubMed ID: 24534133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic microangiopathies (TTP, HUS, HELLP).
    Kappler S; Ronan-Bentle S; Graham A
    Emerg Med Clin North Am; 2014 Aug; 32(3):649-71. PubMed ID: 25060255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura.
    Scully M; Longair I; Flynn M; Berryman J; Machin SJ
    Vox Sang; 2007 Aug; 93(2):154-8. PubMed ID: 17683359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of intravenously abused oral Opana ER-induced thrombotic microangiopathy without plasma exchange.
    Miller PJ; Farland AM; Knovich MA; Batt KM; Owen J
    Am J Hematol; 2014 Jul; 89(7):695-7. PubMed ID: 24668845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.